Fifth Street Management LLC (“Fifth Street”) today announced that its venture lending group, Fifth Street Technology Partners, has worked with Silicon Valley Bank (“SVB”) to refinance an existing credit facility and provide additional growth capital for HealthEdge Software, Inc. (“HealthEdge”), a company that provides an integrated financial, administrative and clinical platform for healthcare payors. The transaction consisted of a $17.5 million second lien term loan from Fifth Street Finance Corp. (NASDAQ:FSC) and a revolver from SVB. HealthEdge is a portfolio company of Psilos Group Managers, LLC (“Psilos”), a healthcare investment firm focused on providing venture and growth capital to companies operating in the healthcare sector.
Innovative Surgical Solution for ENT Surgeons Allows for Faster Cutting and Reduces Fatigue, Improves Comfort
CAMBRIDGE, Mass. – September 29, 2013 – OmniGuide Surgical, a leading developer of advanced energy surgical products, today announced the market introduction of the ELEVATE ENT System, a new product for ENT surgeons. The latest innovation, utilizing OmniGuide’s proven CO₂ laser technology, will be on display in booth # 2140 at the American Academy of Otolaryngology (AAO) meeting in Vancouver from September 29 through October 2, 2013.
“State of the Payor” industry survey finds continued interest in new business models, transparency, mobile and direct-to-consumer offerings, despite struggles with outdated technology and manual processes
Burlington, MA, September 25, 2013 — HealthEdge, provider of the only integrated financial, administrative and clinical platform for healthcare payors delivered via the HealthEdge Cloud or on-site deployment, today announced that findings from the latest “State of the Payor” industry survey show that payors continue to struggle with their outdated technology solutions as they explore new ways to compete in the rapidly evolving healthcare marketplace. The survey of more than one hundred healthcare industry executives from across the country confirms the growing desire among payors to evolve their businesses and adopt next-generation healthcare business models. At the same time, however, many respondents indicated that their existing systems will not effectively support new plan designs, payment reform approaches and increased organizational transparency requirements as well as a number of other key goals. Read More
PatientSafe Solutions, a leader in point-of-care patient safety clinical workflow applications, today announced that it has closed a strategic investment from EDBI, the investment arm of the Singapore Economic Development Board, bringing its total Series C funding to $27 million. The round is led by Merck Global Health Innovation Fund with participation from Camden Partners, TPG Biotech, and Psilos Group. Read More
Capital Will Be Used To Expand Commercialization of the LumaGEM MBI System To Detect Early Cancers in Women with Dense Breast Tissue
SALEM, NH (July 16, 2013) – Gamma Medica, Inc., dedicated to improving patient health through early diagnosis of breast cancer, today announced that it has closed a $16 million Series A financing round from healthcare investment firm Psilos Group Managers, LLC (“Psilos”). This investment will enable Gamma Medica to expand commercialization of the LumaGEM(R) Molecular Breast Imaging (MBI) system and its companion product the LumaGUIDE(R) MBI-guided biopsy module. Read More
At Parkview Medical Center, patient safety and care coordination in real time is made easier thanks to a single mobile device.
In 2007, Pueblo, Colo.-based Parkview Medical Center started using bedside medication administration technology from IntelliDOT Corporation, a vendor in San Diego that specialized in healthcare workflow management solutions. In 2009, IntelliDOT became Patient Safe Solutions, which unveiled its PatientTouch solution, created for Apple’s newest iPod touch—a WiFi-enabled device. Read More
Miraculins Inc. (TSX-V:MOM), (“Miraculins” or the “Company”), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, is pleased to announce that it has executed a final purchase agreement with VeraLight, Inc. (“VeraLight”) on June 28, 2013, to acquire all of the relevant assets, including intellectual property, licenses and regulatory approvals, inventories, data and marketing materials, relating to VeraLight’s SCOUT DS® technology, a ground-breaking diabetes screening technology that non-invasively measures changes in the composition of a person’s skin indicative of pre-diabetes and type 2 diabetes. Read More
Combination of next-generation technology and shared service delivery drive successful transitions to HealthRules® for a growing list of HealthEdge customers
HealthEdge®, provider of the only integrated financial, administrative and clinical platform for healthcare payors, today announced that its continued partnership with NTT DATA, Inc., a leading IT services provider, is helping a growing list of HealthEdge customers, including Independent Health and Riverside Health, achieve a successful transition to the HealthRules product suite. Read More
AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced that the FDA has approved a Pre-market Approval Supplement (PMAS) labeling change allowing inclusion of a summary of the AGILITY Coronary Bifurcation Trial results in the AngioSculpt® PTCA Scoring Balloon Catheter Instructions for Use (IFU).
Panelists at the Health Industry Council’s recent Southwest Transactions conference in Dallas identified 10 promising areas for health investment:
Health insurance exchanges: Dave Eichler, managing member for Psilos Group Managers in New York City, said his company invested six years ago in Medicare exchange company Extend Health, which was sold to Towers Watson. He said Extend Health was successful because Medicare is a guaranteed revenue stream. He said he is unable to predict the impact of exchanges under the Affordable Care Act, but “there will be a big migration.”